Odyssey Therapeutics, Inc. (ODTX) stock
ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.37+0.01 (+0.05%)
Close on Nov 17, 2026Market cap $930.89MP/E –Yield –
Odyssey Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Odyssey Therapeutics's total assets was $483.85M at Jun 30, 2026. For fiscal 2025 it was $269.79M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $269.79M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $483.85M | – |
| Q1 FY2026 | Mar 31, 2026 | $229.07M | – |
| Q4 FY2025 | Dec 31, 2025 | $269.79M | – |
See a number that looks wrong?